BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
Walden Biosciences
/
Howard Mayer, M.D.
HM
Howard Mayer, M.D.
Board Member
Walden Biosciences
Therapeutic Areas
Kidney Disease
Rare Kidney Diseases
Walden Biosciences Pipeline
Drug
Indication
Phase
WAL0921
Rare Kidney Diseases
Phase 2